# EMA safety committee assessed 85 medicine reports in October

> PRAC’s monthly figures list nine safety signals, 49 risk-management plans and 16 post-authorisation studies.

- Canonical URL: https://newsverum.com/en/news/ema-prac-october-2026-pharmacovigilance-outcomes
- Publisher: Newsverum
- Section: Health
- Published: 2026-10-04T01:05:40+00:00
- Updated: 2026-10-12T06:19:32+03:00
- Event / data period: 2026-10-02
- Other editions: [Türkçe](https://newsverum.com/tr/news/ema-prac-october-2026-pharmacovigilance-outcomes.md), [العربية](https://newsverum.com/ar/news/ema-prac-october-2026-pharmacovigilance-outcomes.md), [Français](https://newsverum.com/fr/news/ema-prac-october-2026-pharmacovigilance-outcomes.md), [Español](https://newsverum.com/es/news/ema-prac-october-2026-pharmacovigilance-outcomes.md), [Deutsch](https://newsverum.com/de/news/ema-prac-october-2026-pharmacovigilance-outcomes.md), [Português](https://newsverum.com/pt/news/ema-prac-october-2026-pharmacovigilance-outcomes.md)

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) published October figures after its 28 September–1 October meeting. Its monthly summary lists 85 single assessments of periodic safety update reports, 49 risk-management plans for centrally authorised medicines and 16 post-authorisation safety studies.

The committee reported nine safety signals: five were started and four were ongoing or concluded. EMA said the committee did not start or conclude any referral procedure at the meeting. These counts do not establish that a medicine caused harm or that a new restriction was imposed.

The agency says the monthly figures are based on the draft agenda. It defines a safety signal as information that may suggest a medicine-event association requiring further investigation; a signal alone is not proof of causation.

## Data

### PRAC October statistics

Monthly assessment counts based on the draft agenda.

Methodology: A safety signal is not proof of causation; all counts are based on the draft agenda.

| label | value | unit | period | basis |
|---|---|---|---|---|
| Safety signals | 9 | count | 2026-10 | observed |
| PSUR single assessments | 85 | count | 2026-10 | observed |
| Risk-management plans for centrally authorised medicines | 49 | count | 2026-10 | observed |
| Post-authorisation safety studies | 16 | count | 2026-10 | observed |
| Referrals started, ongoing or concluded | 0 | count | 2026-10 | observed |

Sources: <https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october> · Download data: [JSON](https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes/data/verified-indicators?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes/data/verified-indicators?lang=en&format=csv)

## Sources

- [European Medicines Agency](<https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october>) (Source checked: 2026-10-04; Published: 2026-10-02)
- [European Medicines Agency PRAC committee calendar](<https://www.ema.europa.eu/no/committees/pharmacovigilance-risk-assessment-committee-prac>) (Source checked: 2026-10-04)

## Correction history

- 2026-10-07T00:56:16+03:00: German and Portuguese editions and translations of the data and correction explanations have been added to this article.
- 2026-10-12T06:19:32+03:00: Wording in the translations of data labels or explanations was corrected.

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)
